7
total announcements
BLUEJET.NS · 15 min delayed
Blue Jet Healthcare Limited
Blue Jet Healthcare Limited has been awarded the EcoVadis Silver Medal for its outstanding sustainability management practices, ranking among the top 15% of companies globally.
Blue Jet Healthcare Limited
Blue Jet Healthcare Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming that the company's shares are in demat form and no requests for rematerialization were received during the quarter ended June 30, 2026.
Blue Jet Healthcare Limited
Blue Jet Healthcare Limited has informed the Exchange regarding 'outcome of Investment and Finance Committee' Meeting. The company has approved the issue and allotment of 15,810,276 Equity Shares eligible qualified institutional buyers at the issue price of ₹ 506.00 per Equity Share, aggregating ₹ 8000.00 million. The paid-up equity share capital of the Company stands increased from ₹ 346,930,850 to ₹ 378,551,402.
Blue Jet Healthcare Limited
Blue Jet Healthcare Limited has informed the Exchange regarding the Investment and Finance Committee meeting held on July 9, 2026, where the committee approved the closure of the qualified institutions placement of equity shares, allocation of shares, and adoption of the Placement Document.
Blue Jet Healthcare Limited
Blue Jet Healthcare Limited has informed the Exchange regarding the outcome of its Investment and Finance Committee meeting, which approved the preliminary placement document for a qualified institutions placement of equity shares, fixed the floor price at ₹ 531.70 per share, and authorized the opening of the issue.
Blue Jet Healthcare Limited
Blue Jet Healthcare Limited has submitted its audited standalone financial statements for the financial year ended March 31, 2026, to the NSE. The financial statements are subject to adoption by the shareholders at the ensuing Annual General Meeting.
Blue Jet Healthcare Limited
Blue Jet Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The Trading Window for dealing in the shares of the Company will remain closed for Designated Persons and their immediate relatives from July 1, 2026, till 48 hours after the declaration of Unaudited Standalone Financial Results for the First Quarter ended June 30, 2026.